SPONSOR
Universitaire Ziekenhuizen KU Leuven
Total Trials
24
Recruiting
24
Phases
Phase 2, Phase 3, Phase 2, Phase 4
Conditions studied: AV Block CompleteAV Block-2Nd Degree-Type 1AV BlockBreast CancerHereditary DiseasesInfluenza With PneumoniaInvasive Pulmonary AspergillosisSpastic Cerebral PalsyAcquired Brain InjuryHealthy Volunteers
Universitaire Ziekenhuizen KU Leuven is a clinical research sponsor with 24 registered studies on ClinicalTrials.gov, of which 24 are actively recruiting participants. Research covers conditions including AV Block Complete, AV Block-2Nd Degree-Type 1, AV Block, Breast Cancer.
The trial portfolio spans Phase 2, Phase 3, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Universitaire Ziekenhuizen KU Leuven
How many clinical trials has Universitaire Ziekenhuizen KU Leuven sponsored?
ClinicalMetric currently tracks 24 clinical trials sponsored by Universitaire Ziekenhuizen KU Leuven, of which 24 are actively recruiting participants. These trials cover conditions including AV Block Complete, AV Block-2Nd Degree-Type 1, AV Block. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Universitaire Ziekenhuizen KU Leuven research focus on?
Universitaire Ziekenhuizen KU Leuven clinical trials span AV Block Complete, AV Block-2Nd Degree-Type 1, AV Block, Breast Cancer, Hereditary Diseases, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Universitaire Ziekenhuizen KU Leuven clinical trial?
To participate in a Universitaire Ziekenhuizen KU Leuven trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Universitaire Ziekenhuizen KU Leuven trials with current recruitment status updated daily.
Clinical Trials by Universitaire Ziekenhuizen KU Leuven
NCT07356505
Recruiting
Efficacy and Safety of Micra AV2 Transcatheter Pacing System
AV Block Complete
NCT04531696
Recruiting
UZ/KU Leuven Program for Post-mortem Tissue Donation to Enhance Research
Breast Cancer
NCT03748069
Recruiting
Influenza Associated Aspergillosis In-depth Investigation
Influenza With Pneumonia
NCT05197764
Recruiting
Evaluation of Macroscopic Muscle Growth in Infants and Young Children With Spastic Cerebral Palsy
Spastic Cerebral Palsy
NCT05587036 Phase 2, Phase 3
Recruiting
Effects of Rifaximin on Gut Microbiota and Emotion
Healthy Volunteers
NCT06321991 Phase 2
Recruiting
Nodular Shrinking in Dupuytren Disease
Dupuytren's Disease
NCT07270640
Recruiting
Lifestyle Intervention to Improve Twin Pregnancy Outcomes
Twin Pregnancy, Dichorionic
NCT05344235
Recruiting
Observational Study on Extreme Hypofractionation for Localized Prostate Cancer
Prostate Cancer
NCT06129552
Recruiting
Basal Instincts: Towards Better Understanding of Basal Cell Function in Chronic Rhinosinusitis With Nasal Polyps
Chronic Rhinosinusitis With Nasal Polyps
NCT07237022
Recruiting
The Role of TRP Channels in DPN
Physiological Responses
NCT07535554 Phase 2, Phase 3
Recruiting
The Investigators Will Evaluate the Diagnostic Performance of [18F]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the Current Gold Standard for Inflammation, FDG PET/CT, in Three Patient Cohort: Patients Presenting With Fever of Unknown Origin, IgG4-RD and AxSpA.
Fever of Unknown Origin
NCT06916390 Phase 4
Recruiting
GUselkumAb inteRvention and DIet evaluAtioN for Pouchitis
Pouchitis
NCT07876648
Recruiting
Prospective Trial of [18F]AlF-FAPI-74 for PET Imaging of Fibroblast Activation Protein in Patients With Endometriosis
Endometriosis
NCT06661876
Recruiting
Cardiac RadiothErapy For hEart faiLure
Heart Failure
NCT06988280
Recruiting
Ultrasound-guided Transvaginal Aspiration of Cystic Pelvic Lesions
Pelvic Abscess
NCT01617382
Recruiting
Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
Peritoneal Carcinomatosis
NCT04327570
Recruiting
In-depth Immunological Investigation of COVID-19.
Coronavirus Infections
NCT05051059
Recruiting
Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients
Soft Tissue Sarcoma
NCT07448740
Recruiting
Post-failure Stepwise Heat-Denaturated Protein Introduction for Tolerance Induction in Cow's Milk Allergy Observational Cohort Study
Cow's Milk Protein Allergy
NCT05169593 Phase 4
Recruiting
Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy
Crohn Disease
NCT06017973
Recruiting
The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus
Status Epilepticus
NCT06272292
Recruiting
Biomechanical Investigation of Symptomatic FAI and Two Groups of Asymptomatic Controls
Femoroacetabular Impingement
NCT04695834
Recruiting
Follow-up and Outcome of Operative Treatment With Decompressive Release Of The Peroneal Nerve
Peroneal Nerve Entrapment
NCT04812730
Recruiting
Multimodal Bio-mechanical Analysis of Adult Spinal Deformity With Sagittal Plane Misalignment
Spinal Deformity
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology